Discovery of a potent and long-acting bronchorelaxing capsazepinoid, RESPIR 4-95

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 1, 2008, Pages 125-133

  Skogvall, Staffan ^a   Dalence Guzmán, María F ^b,c   Berglund, Magnus ^b   Svensson, Katrin ^a   Mesic, Admira ^a   Jönsson, Per ^d   Persson, Carl G A ^d   Sterner, Olov ^b  

^a Respiratorius AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Bronchorelaxant; Capsazepinoids; COPD; Human small airways; RESPIR 4 95

Indexed keywords

ACETYLCHOLINE; BRONCHODILATING AGENT; CAPSAZEPINE; CAPSAZEPINOID; DRUG ANALOG; FORMOTEROL; HISTAMINE; LEUKOTRIENE D4; PROSTAGLANDIN D2; RESPIR 4-95; UNCLASSIFIED DRUG;

AIRWAY; ARTICLE; BRONCHODILATATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN TISSUE; MUSCLE CONTRACTION; PRIORITY JOURNAL;

BRONCHODILATOR AGENTS; CALCIUM CHANNEL BLOCKERS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKOTRIENE D4; LUNG; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; RECEPTORS, ADRENERGIC, BETA-2; TETRAHYDROISOQUINOLINES;

EID: 38049024386     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.01.004     Document Type: Article

References (18)

1. Skogvall S, Berglund M, Dalence-Guzmán MF, Svensson K, Jönson P, Persson CGA, et al. Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants. Pulm Pharmacol Ther 2006, in press, doi:10.1016/j.pupt.2006.03.002.
2. Belvisi M.G., Miura M., Stretton D., and Barnes P.J. Capsazepine as a selective antagonist of capsaicin-induced activation of C-fibres in guinea-pig bronchi. Eur J Pharmacol 215 (1992) 341-344
3. Satoh H., Lou Y.-P., and Lundberg J.M. Inhibitory effects of capsazepine and SR 48968 on citric acid-induced bronchoconstriction in guinea-pigs. Eur J Pharmacol 236 (1993) 367-372
4. Roche W.R. Inflammatory and structural changes in the small airways in asthma. Am J Respir Crit Care Med 157 (1998) S191-S194
5. Hasegawa M., Nasuhara Y., Onodera Y., Makita H., Nagai K., Fuke S., et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 (2006) 1309-1315
6. Tulic M.K., and Hamid Q. New insights into the pathophysiology of the small airways in asthma. Clin Chest Med 27 (2006) 41-52
7. Persson C.G.A., and Ekman M. Contractile effects of histamine in large and small respiratory airways. Agents Actions 6 (1976) 389-393
8. Mechiche H., Naline E., Candenast L., Pinto F.M., Birembault P., Advenier C., et al. Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites. Clin Exp Allergy 33 (2003) 887-894
9. Finney M., Karlsson J.-A., and Persson C.G.A. Effects of bronchoconstrictors and bronchdilators on a novel human small airway preparation. Br J Pharmacol 85 (1985) 29-36
10. Wagner E.M., Bleecker E.R., Permutt S., and Liu M.C. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 157 (1998) 447-452
11. Schwartz A., Matlib M.A., Balwierczak J., and Lathrop D.A. Pharmacology of calcium antagonists. Am J Cardiol 55 (1985) 3-7
12. Schwartzstein R.S., and Fanta C.H. Orally administered nifedipine in chronic stable asthma, comparison with an orally administered sympathomimetic. Am Rev Respir Dis 134 (1986) 262-265
13. 4-induced constriction in human small bronchioles. Br J Pharmacol 133 (2001) 243-252
14. Ong Hwei L., and Barritt Greg J. Transient receptor potential and other ion channels as pharmaceutical targets in airway smooth muscle cells. Respirology 9 (2004) 448-457
15. Ferrari M., Olivieri M., De Gasperi M., and Lechi A. Differential effects of nifedipine and diltiazem on methacholine-induced bronchospasm in allergic asthma. Ann Allergy 63 (1989) 196-200
16. Rabe K.F., and Lindén A. Mechanism of duration of action of inhaled long-acting beta2-adrenoceptor agonists. In: Pauwels R., and O'Byrne P.M. (Eds). Beta2-agonists in asthma treatment (1997), Marcel Dekker, New York 131-156
17. Corteling R.L., Li S., Giddings J., Westwick J., Poll C., and Hall I.P. Expression of transient receptor potential C6 and related transient receptor potential family members in human airway smooth muscle and lung tissue. Am J Respir Cell Mol Biol 30 (2004) 145-154
18. Xu S.Z., Zeng F., Boulay G., Grimm C., Harteneck C., and Beech D.J. Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br J Pharmacol 145 (2005) 405-414